Epinoma

Project mission

The objective of the project is the registration of a new immuno-oncology drug for the treatment of melanoma and other cancers, including rare cancers such as mesothelioma or squamous cell carcinoma of the esophagus or carcinoma of the biliary tract. This objective requires the achievement of the aims of the phase 1 study and the subsequent initiation of phase II and III clinical trials to demonstrate clinical efficacy in the above indications.